MedPath

Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug | The Alabama ...

UAB startup TIXiMED Inc. gains FDA clearance for TIX100, an oral Type 1 diabetes drug, to proceed to clinical trials, potentially easing the burden of daily insulin injections.


Reference News

Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug | The Alabama ...

UAB startup TIXiMED Inc. gains FDA clearance for TIX100, an oral Type 1 diabetes drug, to proceed to clinical trials, potentially easing the burden of daily insulin injections.

© Copyright 2025. All Rights Reserved by MedPath